NIS Labs
Klamath Falls, Oregon, 97601, United States
Location status: Recruiting
NCT Number: NCT06754228
Clinical proof-of-concept study, comparing the acute immune impacts of 3 doses of a probiotic strain to a placebo. This study involves twenty-four participants, composed of healthy adults, who will be taking a placebo and 3 different doses of the probiotic at different times. Testing for immune status and cytokine levels will be conducted to determine the acute impact of the probiotic on immune function when compared to a placebo.
Interested in participating?
Request Info18 year–75 year
All sexes
Interventional
Not applicable
Klamath Falls, Oregon, 97601, United States
Location status: Recruiting
Clinical proof-of-concept study comparing the acute immune effects of 3 doses of a probiotic compared to a placebo. The probiotic strain is characterized as Bacillus coagulans JBI-YZ6.3 (BC4U).
24 subjects will participate in a placebo-controlled, escalating dose, cross-over study design, wherein they will be taking placebo, dose 1, dose 2, and dose 3, each separated by a 1-week washout period.
Blood samples are taken 1 hour after participants arrive; the dose is then administered. Samples are taken 1 hour, 2 hours, and 3 hours following administration.
A series of immune panels will be used to determine the acute impacts on immune surveillance, immune cell activation status, immune cell priming, and cytokine profiles.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Bacillus coagulans JBI-YZ6.3 (BC4U)
Time frame: 3 hours
Changes in serum cytokine levels
Time frame: 3 hours
Changes in immune cell trafficking and status of immune cell alertness, ie. the changes in immune cell populations and activation status following consumption:
Numbers of CD3- CD56+ NK cells in blood Numbers of CD3+ CD56+ NKT cells in blood Numbers of CD3+ CD56- T cells in blood Numbers of cells positive for CD25 Numbers of cells positive for CD69
Time frame: 3 hours
Ex vivo immune challenges, documenting the capabilities of anti-bacterial and anti-viral immune responses:
Cytokine levels in 24-hour culture supernatants of ex vivo immune cell cultures in unchallenged cultures Cytokine levels in 24-hour culture supernatants of ex vivo immune cell cultures in lipopolysaccharide-inflamed cultures Cytokine levels in 24-hour culture supernatants of ex vivo immune cell cultures in Poly I:C challenged cultures
Natural Immune Systems Inc
Other
Acute Immune Modulation by Probiotic Strain Bacillus Coagulans JBI-YZ6.3 (BC4U)
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07206407
Immune Surveillance
Klamath Falls, Oregon, United States
View Trial DetailsNCT07195552
Immune Surveillance
Klamath Falls, Oregon, United States
View Trial DetailsNCT07142720
Immune Surveillance, Stem Cell Surveillance
Klamath Falls, Oregon, United States
View Trial DetailsNCT05819424
Immune Surveillance
Klamath Falls, Oregon, United States
View Trial Details